InflaRx (IFRX) Stock Chart & Stock Price History $0.88 -0.01 (-0.58%) As of 09:37 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock InflaRx Stock Price Performance The InflaRx (IFRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 46.97%, with a year-to-date return of -64.57%. In the past month, the stock has increased 11.61%, reflecting recent market activity. As of the latest close, InflaRx traded at $0.88 with a market cap of $59.08 million and volume of 2.67 million shares. Five years ago, the stock traded at $4.92, representing a 82.22% decrease over that period. At the time, it had a market cap of $123.73 million and a volume of 187,408 shares. Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.14%1 Month Performance+11.61%3 Month Performance-10.71%Year-To-Date Performance-64.57%1 Year Performance-46.97%5 Year Performance-82.22% IFRX Stock Chart for Monday, July, 14, 2025 IFRX Chart by TradingView InflaRx Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$0.90$0.88-2.21%$0.93$0.872.67 million shs$59.08 million07/10/2025$0.89$0.90+0.66%$0.92$0.88168,264 shs$60.42 million07/09/2025$0.88$0.89+2.08%$0.90$0.86215,162 shs$60.02 million07/08/2025$0.82$0.88+6.82%$0.89$0.82441,261 shs$58.80 million07/07/2025$0.81$0.82+1.86%$1.00$0.801.02 million shs$55.05 million07/04/2025$0.81$0.81$0.81$0.8056,884 shs$54.04 million07/03/2025$0.81$0.81-0.74%$0.81$0.8056,884 shs$54.04 million07/02/2025$0.80$0.81+1.38%$0.83$0.80137,760 shs$54.45 million07/01/2025$0.79$0.80+1.27%$0.81$0.78190,447 shs$53.70 million06/30/2025$0.81$0.79-2.20%$0.81$0.78171,795 shs$53.03 million Get the Latest News and Ratings for IFRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$0.83$0.81-2.98%$0.84$0.79147,176 shs$54.23 million06/26/2025$0.84$0.83-0.88%$0.85$0.80113,764 shs$55.89 million06/25/2025$0.80$0.84+5.00%$0.85$0.77328,049 shs$56.39 million06/24/2025$0.79$0.80+0.88%$0.82$0.77131,633 shs$53.70 million06/23/2025$0.80$0.79-0.28%$0.82$0.77232,029 shs$53.24 million06/20/2025$0.80$0.80-0.35%$0.81$0.77173,944 shs$53.38 million06/19/2025$0.80$0.80$0.83$0.76392,602 shs$53.57 million06/18/2025$0.77$0.80+3.65%$0.83$0.76392,602 shs$53.57 million06/17/2025$0.78$0.77-1.29%$0.79$0.75294,842 shs$51.69 million06/16/2025$0.78$0.78-0.51%$0.80$0.76251,352 shs$52.36 million06/13/2025$0.80$0.78-2.00%$0.80$0.76819,458 shs$52.63 million Related Companies Editas Medicine Stock Chart Design Therapeutics Stock Chart Tvardi Therapeutics Stock Chart scPharmaceuticals Stock Chart MediWound Stock Chart Kodiak Sciences Stock Chart AC Immune Stock Chart CARGO Therapeutics Stock Chart Larimar Therapeutics Stock Chart CytomX Therapeutics Stock Chart Receive IFRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IFRX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersRefund From 1933: Trump’s Reset May Create Instant WealthTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredThe Next Commodity Crisis Just Got a Name: SilverElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InflaRx N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share InflaRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
